NSN 6505-01-224-0176, 6505012240176
Cancelled -> Replaced by 6505013554645

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 012240176
Codification Country: United States
Item Name Code: INC 36939
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-224-0176

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-224-0176

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-224-0176

National Stock Number (NSN) 6505-01-224-0176, or NIIN 012240176, (levonorgestrel and ethinyl estra) was assigned January 11, 1986 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 1 stock number, 6505013554645.

There are 11 manufacturer part numbers associated with this NSN. 2 of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 7 suppliers. Today, 6 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 6 suppliers are deemed design controlled or valid supply parts.

This part number is actively being procured by the US Government, with procurement history within the last 90 days. There have been 8 contracts issued for this part number, with 8 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 3 different suppliers. The last contract numbers awarded were: SPE2DP25V2724, SPE2DP25V2628, SPE2DP25V1988, SPE2DP25V1376, SPE2DP25V1137. The total value of the awarded contracts has been US$ 5,123.05.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Mar 09, 2016, this NSN's acquisition method was noted as: Suitable for Competitive Acquisition. (Potential sources shall include dealers/distributors.) This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 36939. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505012240176 does not contain precious metals.

This NSN is associated to Schedule B 3006600000: chemical contraceptive preparations based on hormones or spermicides. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.

This information was last updated on Jul 01, 2025.

Technical Characteristics

ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 0.040 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT AND 0.050 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT AND 0.075 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT AND 0.125 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS (TRIVORA) 168S
MEDICAL DESIGNATION AND GRADE: (MDES) UNITED STATES PHARMACOPEIA
SPECIAL FEATURES: (FEAT) 28 TABLETS PER EACH CYCLE COMPACT CONTAINING IN SEQUENCE: 6 TABLETS LEVONORGESTREL 0.050 MG AND ETHINYL ESTRADIOL 0.030 MG FOLLOWED BY 5 TABLETS LEVONORGESTREL 0.075 MG AND ETHINYL ESTRADIOL 0.040 MG FOLLOWED BY 10 TABLETS LEVONORGESTREL 0.125 MG AND ETHINYL ESTRADIOL 0.030 MG FOLLOWED BY 7 TABLETS OF INERT INGREDIENTS. STORE AT 20 - 25 C (68 - 77 F). (SEE USP CONTROLLED ROOM TEMPERATURE).
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 28.000 TABLETS
PRIMARY CONTAINER TYPE: (CQCT) DISPENSER, PLASTIC COMPACT
SUPPLEMENTARY FEATURES: (SUPP) CONTAINS 6 CYCLES OF 28 TABLETS; MEDSEP ITEM FOR DOD,BERLEX LABS
TOTAL PRIMARY CONTAINER QUANTITY: (CSCW) 6
MEDICAL DESIGNATION: (MDES) UNITED STATES PHARMACOPEIA
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS (TRIVORA) 168S